Additional information
White Powder
1207630-52-1
ACI-090615
2-Butyl-3-2`-1-2`-(2H-tetrazol-5-yl)1,1`-biphenyl-4-ylmethyl-2H-tetrazol-5-yl1,1`-biphenyl-4-ylmethyl-1,3-diazaspiro4.4non-1-en-4-one
2-Butyl-3-[[2-[1-[[2-(2H-tetrazol-5-yl)[1,1-biphenyl]-4-yl]methyl]-2H-tetrazol-5-yl][1,1-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
115.2-116.3°C
C39H38N10O
662.79
Ambient
2-8°C
1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2'-[2-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
Hypertension





![sec-BUTYL PACLITAXEL (25 mg) ((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (αR,βS)-α-hydroxy-β-[[(2S)-2-methyl-1-oxobutyl]amino]benzenepropanoate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)